ストックスクリーナーアプリを入手
146.14
2.01%
-3.19
前日終値:
$149.33
開ける：
$147.1
24時間の取引高:
925.31K
Relative Volume:
0.30
時価総額：
$31.14B
収益：
$606.42M
当期純損益:
$-1.28B
株価収益率:
-22.82
EPS:
-6.403
ネットキャッシュフロー:
$-997.58M
1週間 パフォーマンス:
-7.98%
1か月 パフォーマンス:
-4.97%
6か月 パフォーマンス:
+0.71%
1年 パフォーマンス:
+79.44%
1日の値動き範囲:
$145.00
$148.87
1週間の範囲:
$145.00
$161.13
52週間の値動き範囲:
$60.40
$212.75
Insmed Inc Stock (INSM) Company Profile
Compare INSM vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
146.03 | 31.85B | 606.42M | -1.28B | -997.58M | -6.403 |
|
VRTX
Vertex Pharmaceuticals Inc
|
487.31 | 126.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
786.69 | 82.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
757.80 | 47.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.37 | 44.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
311.42 | 35.08B | 4.98B | 69.60M | 525.67M | 0.5198 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-28 | 開始されました | Barclays | Overweight |
| 2026-01-23 | 開始されました | Roth Capital | Buy |
| 2025-12-19 | 再開されました | Truist | Buy |
| 2025-12-04 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-10-28 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-10-20 | 開始されました | Wells Fargo | Overweight |
| 2025-08-20 | 開始されました | William Blair | Outperform |
| 2025-08-13 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 開始されました | Jefferies | Buy |
| 2025-02-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-04-23 | 開始されました | Truist | Buy |
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-07-26 | 開始されました | Guggenheim | Buy |
| 2022-12-09 | 開始されました | Mizuho | Buy |
| 2022-12-07 | 開始されました | Barclays | Overweight |
| 2022-11-18 | 開始されました | BofA Securities | Buy |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2021-12-06 | 開始されました | JP Morgan | Overweight |
| 2021-10-19 | 再開されました | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-12-17 | 開始されました | Berenberg | Buy |
| 2020-10-12 | 再開されました | Stifel | Buy |
| 2019-09-03 | 開始されました | Goldman | Buy |
| 2019-04-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-15 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | アップグレード | Goldman | Neutral → Buy |
| 2019-01-02 | 開始されました | Canaccord Genuity | Buy |
| 2018-08-06 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 開始されました | Goldman | Neutral |
| 2018-04-23 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 開始されました | Morgan Stanley | Overweight |
| 2018-01-18 | 開始されました | Credit Suisse | Neutral |
| 2017-09-05 | 繰り返されました | Evercore ISI | Outperform |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-07-11 | 開始されました | Robert W. Baird | Outperform |
| 2016-03-15 | 開始されました | Stifel | Buy |
| 2015-11-09 | ダウングレード | UBS | Buy → Neutral |
| 2015-10-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-06-09 | 開始されました | Citigroup | Neutral |
| 2014-03-26 | 繰り返されました | HC Wainwright | Buy |
すべてを表示
Insmed Inc (INSM) 最新ニュース
William Blair Investment Management LLC Has $223.94 Million Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Incorporated (INSM) Enters 2026 With Momentum - Finviz
INSM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Insmed (INSM) director gifts shares and details family holdings - Stock Titan
Insmed, Inc. Experiences Revision in Its Stock Evaluation Amid Financial Performance Trends - Markets Mojo
Artisan Partners Limited Partnership Grows Stock Position in Insmed, Inc. $INSM - MarketBeat
Why Insmed Incorporated (INSM) is One of the Best Strong Buy Healthcare Stocks to Invest In - Finviz
Westfield Capital Management Co. LP Lowers Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Thornburg Investment Management Inc. Trims Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Stock Hits Day Low of $148.24 Amid Price Pressure - Markets Mojo
INSMED Chief Legal Officer Sells Shares Worth Over $3.8 Million - TradingView
Insmed (INSM) Q4 2025 Earnings Call Transcript - AOL.com
HC Wainwright Forecasts Insmed's Q3 Earnings (NASDAQ:INSM) - MarketBeat
Brown Advisory Small-Cap Growth Fund's Insmed Inc(INSM) Holding History - GuruFocus
Analysts Are Bullish on Top Healthcare Stocks: Travere Therapeutics (TVTX), Insmed (INSM) - The Globe and Mail
H.C. Wainwright Remains a Buy on Insmed (INSM) - The Globe and Mail
INSM Stock Rating: Mizuho Lowers Price Target Amid Consistent Ou - GuruFocus
Mizuho Issues Pessimistic Forecast for Insmed (NASDAQ:INSM) Stock Price - MarketBeat
Insmed Incorporated (INSM) Gained from Its Lead Product ARIKAYCE - Yahoo Finance
HC Wainwright Comments on Insmed's Q1 Earnings (NASDAQ:INSM) - MarketBeat
Insmed chair and CEO Lewis sells $1.6m in stock By Investing.com - Investing.com Nigeria
Insmed chair and CEO Lewis sells $1.6m in stock - Investing.com
Insmed (INSM) Is Up 6.9% After BRINSUPRI Sales Beat Expectations And 2026 Target SetWhat's Changed - Yahoo Finance
H.C. Wainwright reiterates Buy on Insmed stock, $230 target By Investing.com - Investing.com UK
William Lewis Sells 10,699 Shares of Insmed (NASDAQ:INSM) Stock - MarketBeat
Insmed (INSM) CEO Lewis exercises options and sells 10,699 shares - Stock Titan
INSM: HC Wainwright & Co. Reiterates Buy Rating with $230 PT | I - GuruFocus
Mizuho Securities Cuts Insmed Price Target to $204 From $211, Maintains Outperform Rating - marketscreener.com
Insmed (NASDAQ:INSM) Given Buy Rating at HC Wainwright - MarketBeat
H.C. Wainwright reiterates Buy on Insmed stock, $230 target - Investing.com
Patient Square Capital LP Reduces Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed Gets UK Marketing Authorization for Non-Cystic Fibrosis Bronchiectasis Treatment - marketscreener.com
Hillsdale Investment Management Inc. Sells 7,000 Shares of Insmed, Inc. $INSM - MarketBeat
Bank of America Securities Reaffirms Their Buy Rating on Insmed (INSM) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Talkspace (TALK) and Insmed (INSM) - The Globe and Mail
Wells Fargo Lowers Price Target for Insmed (INSM) Amid Overweigh - GuruFocus
Breaking Down Insmed: 16 Analysts Share Their Views - Benzinga
Wall Street Analysts Think Insmed (INSM) Could Surge 33.6%: Read This Before Placing a Bet - Finviz
Insmed Lags on Q4 Earnings, Stock Gains on 2026 Brinsupri Sales View - Bitget
Insmed Q4 Reinforces Confidence in Brinsupri Growth, RBC Says - marketscreener.com
Insmed May Top Revenue Target for Bronchiectasis Drug Brinsupri, Morgan Stanley Says - marketscreener.com
Insmed Incorporated (NASDAQ:INSM) Q4 2025 Earnings Call Transcript - Insider Monkey
Skandinaviska Enskilda Banken AB publ Grows Position in Insmed, Inc. $INSM - MarketBeat
Morgan Stanley Lifts Price Target on Insmed to $166 From $162, Keeps Equalweight Rating - marketscreener.com
Insmed, Inc. $INSM Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
Fiera Capital Corp Grows Stock Position in Insmed, Inc. $INSM - Defense World
Insmed (INSM) Poised for 2026 Upside With Potential $1.3B Arikayce Sales Boost, Roth/MKM Initiates Buy - Finviz
Decoding Insmed Inc (INSM): A Strategic SWOT Insight - GuruFocus
Insmed: Q4 Earnings Snapshot - theheraldreview.com
Insmed jumps as new drug launch momentum drives bullish 2026 revenue outlook - Quiver Quantitative
Insmed Inc (INSM) Q4 2025 Earnings Call Highlights: Strong Brin Suri Launch and Promising 2026 ... By GuruFocus - Investing.com Canada
Insmed Inc (INSM) 財務データ
収益
当期純利益
現金流量
EPS
Insmed Inc (INSM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Smith Michael Alexander | Chief Legal Officer |
Feb 24 '26 |
Sale |
155.77 |
24,774 |
3,859,157 |
51,871 |
2.60%
1.10%
大文字化:
|
ボリューム (24 時間):